Tokyo, Japan

Kosuke Masui

This inventor holds 1 USPTO granted patent. Top assignees: Gellycle Co., Ltd., The University of Tokyo. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kosuke Masui. Retrieved from https://idiyas.com/inventor/kosuke-masui-l49wb9zy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kosuke Masui and a Gel Material for Tendon and Ligament Repair.

Introduction

Kosuke Masui is an inventor associated with Tokyo, Japan, and research and development at the University of Tokyo and Gellycle Co., Ltd. His work includes a gel material intended to support the healing of injured or ruptured tendons and ligaments.

Latest Patents

Masui is associated with 1 patent, titled “Gel Material for Treating Tendon or Ligament.” The invention describes a polymer gel designed to suppress type III collagen expression and limit scar tissue from entering the injured area. Its aim is to encourage healing by cells within the tendon or ligament and help restore the tissue’s original function.

Career Highlights

Masui’s listed affiliations include the University of Tokyo and Gellycle Co., Ltd. The patent reflects an application of polymer-gel technology to tendon and ligament repair.

Collaborations

Takamasa Sakai and Taku Saito are identified as Masui’s coworkers. Their names are associated with the collaborative research context surrounding his invention.

Conclusion

Kosuke Masui’s patent focuses on a polymer gel approach to tendon and ligament treatment, with the goal of reducing scar tissue formation and supporting functional healing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…